Shopping Cart
Remove All
Your shopping cart is currently empty
PPARγ agonist12 (compound 9i) is a potent and selective PPARγ agonist, exhibiting EC50 values of 3.98 μM for PPARγ and 15.42 μM for PPARδ. It enhances insulin secretion and demonstrates antidiabetic properties.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | PPARγ agonist12 (compound 9i) is a potent and selective PPARγ agonist, exhibiting EC50 values of 3.98 μM for PPARγ and 15.42 μM for PPARδ. It enhances insulin secretion and demonstrates antidiabetic properties. |
| In vivo | Administered at 36 mg/kg orally in a single dose, PPARγ agonist 12 demonstrates antidiabetic effects in NA-Streptozotocin-induced diabetic rats. |
| Formula | C25H23N3O6S2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.